Dalton Pharma Services. a provider of chemistry, drug development, and dosage-form manufacturing services, has expanded cGMP sterile powder-filling capabilities at its facility in Toronto as part of its ongoing focus on sterile processing and manufacturing. The expansion includes the addition of a high-speed automated sterile powder-filling line to enable filling of large commercial batches of vials. The new cGMP equipment will be installed in a dedicated suite with local Class A environment and isolator style containment.

Dalton will also be adding intermediate scale cGMP sterile powder-filling equipment optimized to produce small to medium-sized clinical trial batches. The new mid-scale equipment will be operated under a Class A environment and containment system. The new sterile manufacturing capacity is semi-automated and provides 100% check weighing for batches up to 10,000 vials.

These new capabilities complement ecent aseptic liquid-filling enhancements at Dalton's Toronto location. The expansion is supported by CAD$ 2.085 million (US$2.62 million) in FedDev Ontario funding through the Investing in Business Growth and Productivity Initiative. FedDev Ontario (Federal Economic Development Agency for Southern Ontario) is focused on helping established businesses to expand their operations and invest in productivity improvements.

Source: Dalton Pharma Services